LC/MS/MS Method for Analysis of Naphthenic Acids from Aqueous Samples

Similar documents
Million B. Woudneh, M. Coreen Hamilton, Jonathan P. Benskin, Guanghui Wang, John R. Cosgrove SETAC, Nashville November 2013

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Development and Validation of a Polysorbate 20 Assay in a Therapeutic Antibody Formulation by RP-HPLC and Charged Aerosol Detector (CAD)

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

SUPPORTING INFORMATION FOR: CONCENTRATIONS OF POLYBROMINATED DIPHENYL ETHERS, HEXABROMOCYCLODODECANES AND TETRABROMOBISPHENOL-A IN BREAST MILK FROM

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

A RAPID AND SENSITIVE ANALYSIS METHOD OF SUDAN RED I, II, III & IV IN TOMATO SAUCE USING ULTRA PERFORMANCE LC MS/MS

Measuring Lipid Composition LC-MS/MS

Rapid Lipid Profiling of Serum by Reverse Phase UPLC-Tandem Quadrupole MS

Validation Report 8. EURL for Cereals and Feeding stuff National Food Institute Technical University of Denmark

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

LC-MS/MS for the quantification of Peptide biomarker and mixture of closely related Protein in formulation

A Novel Platform of On-line Sample Pre-treatment and LC/MS/MS Analysis for Screening and Quantitation of Illicit Drugs in Urine

Determination of Amantadine Residues in Chicken by LCMS-8040

Supporting information

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Supporting Information

The Comparison of High Resolution MS with Triple Quadrupole MS for the Analysis of Oligonucleotides

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

Key Advantages of Comprehensive Cannabis Analysis

vii LIST OF TABLES TABLE NO DESCRIPTION PAGE 1.1 System Suitability Parameters and Recommendations Acidic and Alkaline Hydrolysis 15

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column

Analytical Method Development for USP Related Compounds in Paclitaxel Using an Agilent Poroshell 120 PFP

What You Can t See Can Hurt You. How MS/MS Specificity Can Bite Your Backside

Matrix Factor Determination with the Waters Regulated Bioanalysis System Solution

Surviving Matrix Effects Experiments. Grace van der Gugten St. Paul s Hospital, Vancouver, BC, Canada

Matrix-induced Signal Enhancement of Propamocarb in LC-MS/MS

Performance of an ultra low elution volume 96-well plate

Quantitative Analysis of Vit D Metabolites in Human Plasma using Exactive System

Dienes Derivatization MaxSpec Kit

Analysis of Limonin in Citrus Juice Using QuEChERS and LC-MS/MS

SUPPLEMENTARY DATA. Materials and Methods

LC/MS/MS Analysis of Metabolites of Synthetic Cannabinoids JWH-018 and JWH-073 in Urine

Title: Pharmacokinetics of daikenchuto, a traditional Japanese medicine (Kampo) after. single oral administration to healthy Japanese volunteers

LC-MS/MS Method for the Determination of 21 Opiates and Opiate Derivatives in Urine

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Analysis of Cholesterol-Lowering Drugs (Statins) Using Dried Matrix Spot Technology

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

Quantitative Analysis of Amphetamine-Type Drugs by Extractive Benzoylation and LC/MS/MS. Application. Introduction. Authors. Abstract.

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

[ APPLICATION NOTE ] High Sensitivity Intact Monoclonal Antibody (mab) HRMS Quantification APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine

Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS

Effective use of Pharmacopeia guidelines to reduce cost of chromatographic analysis for Fluticasone propionate

Analysis of drugs of abuse in biological matrix using Time of Flight technology

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

Automated Purification and Analytical Reinjection of a Small Molecule Drug, Probenecid, on a Gilson LC/MS Dual Function System

Glycerolipid Analysis. LC/MS/MS Analytical Services

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

SEPARATION OF BRANCHED PFOS ISOMERS BY UPLC WITH MS/MS DETECTION

Application Note LCMS-108 Quantitation of benzodiazepines and Z-drugs in serum with the EVOQ TM LC triple quadrupole mass spectrometer

Development and Validation of a Liquid Chromatography- Mass Spectrometry method for analysis of Oxysterols in Human Plasma

Summary Chapter 8 CHAPTER 8. Summary. Page 173

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Urine Using UHPLC-TOF

Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

Quantification of Budesonide Using UPLC and Xevo TQ-S

About bioassay of Oximes:? New isolation alternatives from biomatrices? Chromatographic separation issues? Reserve on using MS or MS/MS detection

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Run 1 Run 2 TDP PLP TDP PLP. 3.0e5 2.8e5 2.2e5. 2.6e5 2.4e5. 2.2e5 2.0e5. Intensity, cps. 1.8e5 1.6e5 1.4e5 1.2e5 1.0e5 4.0e4. 2.0e e5 1.

Pesticide Residue Analysis in Whole Milk by QuEChERS and LC-MS/MS

Benefits and Characteristic Applications of High Resolution GC/MS and LC/MS. Frank David RIC and Ghent University

A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.

Authors. Abstract. Introduction. Environmental

New Methodologies for POPs Analysis using Orbitrap GC-MS in Official Food Control

Using RP-HPLC with Fluorescence Detection and SEC C for Sample Preparation and Its Application for Different Food Samples

A comparison study of the analysis of volatile organic acids and fatty acids

Neosolaniol. [Methods listed in the Feed Analysis Standards]

Abstract. Introduction

Rapid Gradient and Elevated Temperature UHPLC of Flavonoids in Citrus Fruit

Overcoming the Challenges of Sample Preparation and LC/MS/MS Method Development for Clinical Applications

Journal of Chemical and Pharmaceutical Research, 2017, 9(9): Research Article

SUPPLEMENTARY MATERIAL

Institute of Toxicology Clinical Toxicology and Pharmacology Berliner Betrieb für Zentrale Gesundheitliche Aufgaben, Berlin

Secrets to Successful GC-MS/MS Pesticide Method Development

A FORENSIC TOXICOLOGY METHOD FOR THE DETERMINATION OF DESOMORPHINE, HEROIN, METHADONE, BUPRENORPHINE AND METABOLITES IN URINE USING LC/MS QQQ

Efficient Quantitative Analysis of THC and Metabolites in Human Plasma Using Agilent Captiva EMR Lipid and LC-MS/MS

LC-MS/MS Method for the Determination of Tenofovir from Plasma

Development and Validation of Multiresidue Pesticide Methods at FDA/CFSAN

Development and Validation of RP-HPLC Method for the Estimation of Gemigliptin

Identification of Ginsenosides Using the SCIEX X500R QTOF System

International Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system

Supplementary Information. Effects of Perfluorooctanoic Acid on Metabolic Profiles in Brain and Liver of Mouse by a

Supporting Information. Transformation Pathways of the Recalcitrant Pharmaceutical Compound

Pelagia Research Library

Analysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology

Determination of 13 Free Fatty Acids in Pheretima Using Ultra-Performance LC-ESI-MS

Method Development for the Analysis of Endogenous Steroids Using Convergence Chromatography with Mass Spectrometric Detection

Paul D. Rainville Ph.D. Health Sciences Group Waters Corporation Waters Corporation 1

Transcription:

LC/MS/MS Method for Analysis of Naphthenic Acids from Aqueous Samples By: Million Woudneh 1, Coreen Hamilton 1, Guanghui Wang 1, Preston McEachern 2 1 Axys Analytical Services Ltd., Sidney, BC 2 Alberta Environment, Edmonton, AB

1. Introduction Naphthenic Acids (NA) Definition A complex mixture of saturated, cyclic and non cyclic carboxylic acids described by the formula CnH2n+zO2, Where, n=# of C atoms, z, represents hydrogen deficiency Occurrence Naturally occurring in crude oils and oil sand bitumens Extracted from oil sands during the caustic hot water production process Project purpose Develop a sensitive method that is: able to sufficiently characterize NAs for fingerprinting is useful for comparative data evaluation Overcome the false positive effects associated with GC MS

Model compounds Model compounds were used for initial method development Refined Merichem Abietic acid Model Compounds Cyclohexanecarboxylic acid Cyclohexanebutyric acid Decanoic acid 1 pyrenebutyric acid (PYB) 5ß cholanic acid 2. Experimental Approach Refined Merichem (from Merichem chemicals) was used to validate method Table 1. Internal Standards n Decanoic acid d19 n Dodecanoic acid d23 n Tetradecanoic acid d27 n hexadecanoic acid d31 n octadecanoic acid d35 n Eicosanoic acid d39 Instrumental method ( ) ESI vs (+) ESI LC/MS/MS ( ESI) NAs produce good parent signal but poor product ions (+ESI) derivatization with EDC, EDC= 1 Ethyl 3 [3 dimethylaopropyl]carbodiimide Hydrochloride

2.1 (+ESI) Parent Ions Selection WG29394 WG29394 L1321-9 63 (1.173) 157 1 214 328 172 +155 Scan ES+ 2.29e8 13 189 13 128 156 175 173 155 21 23 235 236 Decanoic acid derivative 143 218 237 159 258 329 425 115 439 219 238 258 31 391 27 411 39 33 365 411 44 493 58 453 47 52 552565 582 585 m/z 1 125 15 175 2 225 25 275 3 325 35 375 4 425 45 475 5 525 55 575 6 In both cases no signal in ( ESI) WG29568 1ul/, unit mass res. WG29568 L13132-1 128 (2.374) Cm (18:149) 1 347 191 +155 Scan ES+ 1.66e8 129 156 188 237 128 175 173 187 21 216 23 235 Decanoic acid d19 derivative 13 13 258 189 114 441 142 217 157 346 349 425 238 274 311 276 32 338 357 376 412 386 457 47 493 495 526 528 546 562 586 588 m/z 1 125 15 175 2 225 25 275 3 325 35 375 4 425 45 475 5 525 55 575 6 439

WG29394 WG29394 L1321-9 63 (1.173) 157 1 13 128 13 143 189 23 156 175 21 173 155 214 235 218 236 237 328 Scan ES+ 2.29e8 159 258 329 425 115 439 219 238 258 31 391 27 411 39 33 365 411 44 493 58 453 47 52 552565 582 585 m/z 1 125 15 175 2 225 25 275 3 325 35 375 4 425 45 475 5 525 55 575 6 2.2 (+ESI) Parent and Daughter Ions Selection Table 2. Analyte Decanoic acid Decanoic acid d19 Parent ions 328 347 Selected MRM Daughter ions 212 257 129 231 276 129 In both cases no signal in (-ESI) WG29568 1ul/, unit mass res. WG29568 L13132-1 128 (2.374) Cm (18:149) 1 347 Scan ES+ 1.66e8 128 129 156 188 175 216 23 173 187 21 235 237 13 13 258 189 114 441 142 217 157 346 349 425 238 274 311 276 32 338 357 376 412 386 457 47 493 495 526 528 546 562 586 588 m/z 1 125 15 175 2 225 25 275 3 325 35 375 4 425 45 475 5 525 55 575 6 439

2.3 Target Naphthenic Acids Target naphthenic acids were selected based on: prevalence in surface water samples presence in refined Merichem Table 3. n 9 1 11 12 13 14 15 16 17 18 19 2 21 22 23.17 = not applicable peak area for various naphthenic acids in a surface water sample z= 12 1.28 2.58 3.52 3.43 2.32 1.85.97.43 z= 1 1.9 1.54 1.7 1.59 1.1.71.39.14.3 z= 8.68 1.86 2.7 2.6 1.8 1.15.54.24.8.2 z= 6.62 2.13 5.25 7.59 7.47 4.92 2.68 1.42.6.29.5.1 z= 4.41 1.5 3.33 5.7 5.48 4.45 2.77 1.47.81.35.15.2 z= 2.1.28.53.77.9.68.46.32.15.6.2 z=.13.2.4.5.6.5.2 Total.13.51 2.4 6.1 11.8 18.3 19.5 16. 11.3 6.95 4.11 2.6.72.23

2.4 Analyte Separation Separation by z number Sample Chromatograms for isomer group n=17, Z= 12 to for a solution of purified Merichem (154 ug/ml) NA9J_238S5 Sm ooth(sg,2x1) 1,WG31245,1/1ul WG31245-12,,SPM 1 5.58 C17H22O2 (NA Z -12) 2.38 28.3 F1:MRM of 32 channels,es+ 414.>129 4.357e+5 NA9J_238S5 Sm ooth(sg,2x1) 1,WG31245,1/1ul WG31245-12,,SPM C17H24O2 (NA Z -1);22.37 1 5.93 13.58 F1:MRM of 32 channels,es+ 416.>129 2.231e+5 NA9J_238S5 Sm ooth(sg,2x1) 1,WG31245,1/1ul WG31245-12,,SPM 1 5.65 8.91 C17H26O2 (NA Z -8) 24.77 F1:MRM of 32 channels,es+ 418.>129 4.263e+5 NA9J_238S5 Sm ooth(sg,2x1) 1,WG31245,1/1ul WG31245-12,,SPM 1 NA9J_238S5 Sm ooth(sg,2x1) 1,WG31245,1/1ul WG31245-12,,SPM 1 NA9J_238S5 Sm ooth(sg,2x1) 1,WG31245,1/1ul WG31245-12,,SPM 1 F2:MRM of 32 channels,es+ C17H28O2 (NA Z -6) 42.>129 26.26 1.86e+6 F2:MRM of 32 channels,es+ C17H3O2 (NA Z -4) 422.>129 27.25 5.115e+6 F2:MRM of 32 channels,es+ C17H32O2 (NA Z -2) 424.>129 28.1 4.354e+6 NA9J_238S5 Sm ooth(sg,2x1) 1,WG31245,1/1ul WG31245-12,,SPM 1 F2:MRM of 32 channels,es+ C17H34O2 (NA Z -) 426.>129 28.81 1.555e+6 31.57 1. 15. 2. 25. 3. 35.

2.4 Analyte Separation Separation by n number Sample Chromatograms for isomer group n=12 to n19 for Z= 6 for a solution of purified Merichem (154 ug/ml) NAP_15S11 Smooth(SG,2x1) 1,WG34185,1/1ul WG34185-14,i,SAR MC NA 98-2 98-2 98-2 NAP_15S11 Smooth(SG,2x1) 1,WG34185,1/1ul WG34185-14,i,SAR MC NA 98-2 C12H18O2 (NA Z -6);12.55;7782365.;4138734* 9.66 NAP_15S11 Smooth(SG,2x1) 1,WG34185,1/1ul WG34185-14,i,SAR MC NA C13H2O2 (NA Z -6);16.13;17679876.;659392 NAP_15S11 Smooth(SG,2x1) 1,WG34185,1/1ul WG34185-14,i,SAR MC NA C14H22O2 (NA Z -6);19.16;2282282.;743422* C15H24O2 (NA Z -6);22.33;1786836.;6854148* F1:MRM of 32 channels,es+ 349.9>129 4.22e+6 F1:MRM of 32 channels,es+ 363.9>129 6.695e+6 F1:MRM of 32 channels,es+ 378.>129 7.985e+6 F1:MRM of 32 channels,es+ 392.>129 6.96e+6 NAP_15S11 Smooth(SG,2x1) 1,WG34185,1/1ul WG34185-14,i,SAR MC NA 98-2 F1:MRM of 32 channels,es+ 46.>129 C16H26O2 (NA Z -6);24.72;1184694.;521842* 5.298e+6 NAP_15S11 Smooth(SG,2x1) 1,WG34185,1/1ul WG34185-14,i,SAR MC NA 98-2 NAP_15S11 Smooth(SG,2x1) 1,WG34185,1/1ul WG34185-14,i,SAR MC NA 98-2 F2:MRM of 32 channels,es+ 42.>129 C17H28O2 (NA Z -6);26.48;6575263.5;337946* 3.431e+6 F2:MRM of 32 channels,es+ 434.>129 C18H3O2 (NA Z -6);27.88;331819.75;1598737 1.64e+6 NAP_15S11 Smooth(SG,2x1) 1,WG34185,1/1ul WG34185-14,i,SAR MC NA 98-2 F2:MRM of 32 channels,es+ 448.>129 C19H32O2 (NA Z -6);29.1;1357979.25;712858* 7.238e+5 6. 8. 1. 12. 14. 16. 18. 2. 22. 24. 26. 28. 3. 32. 34. 36.

2.5 Standard characterization and Analyte Quantification Analyte Quantification Two quantification standards were selected: n Decanoic acid d19 and n hexadecanoic acid d31 Atrazine 13C3 was used as injection (recovery) standard Response factor from 1 pyrenebutyric acid was used for target analyte quantification Merichem Characterization 32.8 ug of purified Merichem was detered to be equivalent to 53.2 ug of NA as pyrenebutyric acid (PYB) equivalents (detered from six replicates) The concentration of each NA isomer group was characterized using PYB

3. Method Summary Analysis Flowchart Preparation of POCIS samples Extraction of POCIS samples + Column elution with 6 ml of MeOH Extract Derivatization +1 EDC at 6 o C Instrumental Analysis (+ESI) LC/MS/MS Data Quantification and Reporting Data reported as PYB

4. Method Performance Data Table 4. Demonstration of Precision and Accuracy Isomer group C12 Z1 C12 Z8 C12 Z6 C12 Z4 C12 Z2 C12 Z C12 Z= to 1 Average ( Rec.) n=5 93.7 95.4 92.7 94.2 95.5 92. 93.9 RSD 6.2 5.8 8.9 9.1 7.6 4. 6.5 C13 Z= to 1 C14 Z= to 12 C15 Z= to 12 C16 Z= to 12 C17 Z= to 12 C18 Z= to 12 C19 Z= to 12 C2 Z=2 to 12 C21 Z=2 to 12 95.3 13 12 16 112 12 113 96.2 13 11 14 16 19 22 25 25 12 9.5

4.1 Field sample data Percentage Peak Intensities for NA in Purified Merichem 9 8 PeakArea 7 6 5 4 3 2 1 12 13 14 15 16 17 18 19 2 21 Z= Z=-4 Z=-8 Z=-12 n values Z=-12 Z=-1 Z=-8 Z=-6 Z=-4 Z=-2 Z= Percentage Peak Intensities for NA in Surface Water Sample from Northern Alberta 8 7 Peak Area 6 5 4 3 2 1 12 13 14 15 16 17 18 19 2 21 z= z=-4 z=-8 z=-12 n values z=-12 z=-1 z=-8 z=-6 z=-4 z=-2 z=

8 6 4 2 4.1 Field sample data cotd Concentrations of NA in surface water samples from Northern Alberta as PYB equivalents n=12, z=-6 n=12, z= n=13, z=-2 n=14, z=-6 n=14, z= n=15, z=-8 n=15, z=-2 n=16, z=-1 n=16, z=-4 n=17, z=-12 n=17, z=-6 n=17, z= n=18, z=-8 n=18, z=-2 n=19, z=-1 n=19, z=-4 n=2, z=-1 n=2, z=-4 n=21, z=-12 n=21, z=-6 NA isomer group ng/sample

Summary #1. #2. #3. #4. #5. First quantitative LC/MS/MS method for analysis of Naphthenic acids The method is based on derivatization of NA compounds with 1 EDC Naphthenic acids are separated based on carbon number and extent of cyclization 1 Pyrenebutyric acid simplifies quantification and data interpretation Suitability of the method is demonstrated by analysis of surface water samples from North Alberta

Supplemental information

Demonstration of Method Linearity Example Linear Regression 4 45 PYB equivalents of n= 12 (ng) 3 2 1 R 2 =.9989 R 2 =.9976 R 2 =.9997 R 2 =.9971 1 2 3 4 5 6 7 8 9 Amount of NA (ug) Linear (n=12, z=-12 (right) Linear (n=12, z= (right) Linear (n=21, z=12 (left) Linear (n=21, z= (left) 3 15 PYB equivalents of n=21 (ng)

WG29394 WG29394 L1321-9 63 (1.173) 157 1 13 128 13 143 189 23 156 175 21 173 155 214 235 218 236 237 328 Scan ES+ 2.29e8 159 258 329 425 115 439 219 238 258 31 391 27 411 39 33 365 411 44 493 58 453 47 52 552565 582 585 m/z 1 125 15 175 2 225 25 275 3 325 35 375 4 425 45 475 5 525 55 575 6 WG29568 1ul/, unit mass res. WG29568 L13132-1 128 (2.374) Cm (18:149) 1 13 128 129 13 156 188 175 216 23 173 187 21 235 237 258 347 Scan ES+ 1.66e8 189 114 441 142 217 NA +EDC product 157 346 349 425 238 274 311 276 32 338 357 376 412 386 457 47 493 495 526 528 546 562 586 588 m/z 1 125 15 175 2 225 25 275 3 325 35 375 4 425 45 475 5 525 55 575 6 439 (+ESI) Product and Daughter Ions Selection Naphthenic acid Table 2. Analyte Decanoic acid Decanoic acid d19 Parent ions 328 347 Selected MRM Daughter ions 212 257 129 231 276 129 In both cases no signal in (-ESI) Proposed Fragmentation Pattern EDC R1 = Alkyl from NA R2 = CH 3 CH 2 -

Analyte Separation, A note on Z= analytes NA9J_238S1 Smooth(SG,2x1) 1,WG31245,1/1ul WG31245-11,, BLK 1 Laboratory blank F1:MRM of 32 channels,es+ 356.>129 C12H24O2 (NA Z ) 2.612e+6 24.35 1381249.25 2593763 15.14 6. 8. 1. 12. 14. 16. 18. 2. 22. 24. 26. 28. NA9J_238S5 Smooth(SG,2x1) 1,WG31245,1/1ul WG31245-12,,SPM 1 Field sample C12H24O2 (NA Z ) 22.79 3512178. 898136 F1:MRM of 32 channels,es+ 356.>129 24.35 2.318e+7 Laboratory background due to fatty acids is a challenge in NA analysis This can be corrected by consistently taking out the sharp peaks corresponding to the straight chain isomer for Z= and sometimes for Z=-2 6. 8. 1. 12. 14. 16. 18. 2. 22. 24. 26. 28.

Chromatographic conditions Table Time () 2 3 22 36 LC-Gradient Mobile phase composition A =7 B = 3 A = 5 B = 5 A = 45 B = 55 A = 2 B = 8 A = B =1 LC flow (ml/).2.2.2.18.18 38 38.5 41.5 A = B = 1 A = 7 B =3 A =7 B = 3 Column = Xtera C18, 1 cm, 2.1 mm i.d., 3.5 µm Solvent A =.1 HCOOH &.1 HCOONH4 in HPLC H2O Solvent B = Methanol.2.2.2

Chromatographic conditions Analysis batch compositions Lab Blank uses 5 mg HLB Spiked Matrix uses 5 mg HLB spiked SAR (surrogate, authentic and recover mix) Calibration linear calibration to demonstrate linearity Model compound calibration (PYB) bracketing Run order Linearity model compound linearity Bracketing Cal Model compound solvent SAR Bracketing cal model compound processed sample SAR (surrogate, authentic and recover mix) Solvent SAR - containing Merichem NA Solvent SAR containing model compound NA Spiked sample processed NA spiked SAR Solvent blank Method blank